On Friday, ProKidney Corp (NASDAQ: PROK) opened lower -5.60% from the last session, before settling in for the closing price of $2.5. Price fluctuations for PROK have ranged from $0.46 to $7.13 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 15.66% at the time writing. With a float of $99.34 million, this company’s outstanding shares have now reached $133.42 million.
ProKidney Corp (PROK) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of ProKidney Corp is 26.41%, while institutional ownership is 30.46%. The most recent insider transaction that took place on Jul 08 ’25, was worth 312,510. In this transaction Chief Regulatory Officer of this company sold 103,480 shares at a rate of $3.02, taking the stock ownership to the 0 shares. Before that another transaction happened on Jul 08 ’25, when Company’s Officer proposed sale 103,480 for $0.61, making the entire transaction worth $62,761.
ProKidney Corp (PROK) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted -0.14 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.22) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.13 per share during the current fiscal year.
ProKidney Corp (NASDAQ: PROK) Trading Performance Indicators
Check out the current performance indicators for ProKidney Corp (PROK). In the past quarter, the stock posted a quick ratio of 11.48. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1310.40.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.56, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of ProKidney Corp (PROK)
Analysing the last 5-days average volume posted by the [ProKidney Corp, PROK], we can find that recorded value of 1.31 million was lower than the volume posted last year of 5.53 million. As of the previous 9 days, the stock’s Stochastic %D was 63.79%.
During the past 100 days, ProKidney Corp’s (PROK) raw stochastic average was set at 28.48%, which indicates a significant decrease from 47.73% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.18 in the past 14 days, which was lower than the 0.29 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.45, while its 200-day Moving Average is $1.57. Now, the first resistance to watch is $2.47. This is followed by the second major resistance level at $2.59. The third major resistance level sits at $2.66. If the price goes on to break the first support level at $2.28, it is likely to go to the next support level at $2.21. Should the price break the second support level, the third support level stands at $2.10.
ProKidney Corp (NASDAQ: PROK) Key Stats
There are currently 294,282K shares outstanding in the company with a market cap of 694.51 million. Presently, the company’s annual sales total 80 K according to its annual income of -61,190 K. Last quarter, the company’s sales amounted to 220 K and its income totaled -16,550 K.
